Clinical Trials Directory

Trials / Completed

CompletedNCT02640105

Cluster Headache, Addictions and Vascular Function

Cluster Headache (CH), Addictions and Vascular Function

Status
Completed
Phase
Study type
Observational
Enrollment
95 (actual)
Sponsor
University Hospital, Bordeaux · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cluster headache (CH) is one of the most painful primitive headaches. Developments in neuroimaging have demonstrated activation of the ipsilateral hypothalamic and orexinergic system, which is similar in patients with addictions. CH has strong links to the vascular system but there is no study measuring endothelial function in CH sufferers.

Detailed description

Several studies have shown an association between Cluster headache (CH) and smoking. However, no data exists on the link between CH and other addictions, and impact of these addictions on clinical characteristics of the disease. In addition, despite the strong biological link between CH and the vascular system, systematic investigations about vascular functions in CH patients are lacking. This will be a prospective cohort study of 150 patients with CH, conducted in the Headache Center in Bordeaux, France.

Conditions

Interventions

TypeNameDescription
OTHERNeurological clinical examinationDiagnostic and description of cluster headache
OTHERPsychological clinical examinationScale and questionnaires
OTHERQuestionnairesPsychopathological and cognitive questionnaires
OTHERBlood sampleBlood sample for DNA collection
OTHEREndothelial function measurementEndothelial function will be measured with a noninvasive Peripheral Arterial Tone (PAT) signal technology using the EndoPAT device

Timeline

Start date
2014-06-25
Primary completion
2016-06-10
Completion
2016-06-10
First posted
2015-12-28
Last updated
2022-03-31

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02640105. Inclusion in this directory is not an endorsement.